michigan glp-1 gastrointestinal obstruction class action While many patients are seeing life-changing results with medications, doctors say the medications can also come with risks if they are not dosed properly: https://www.wkrg.com/news/experts-warn-of-dosing-issues-with-glp-1-weight-loss-drugs MRCP - Gastrointestinal (GI) Side

Your previous ways to lose weight no longer work, but theres a hormonal explanation to explain why new strategies have to be used to reach a healthy weight, notes Dr

Your metabolism seems broken

The FDA has consistently warned about the risks of compounded semaglutide products

Discontinuation studies found that stopping after 3-6 months resulted in 50-70% weight regain within the following year

Optimizing Muscle Gain While on Tirzepatide Injections Many patients taking Tirzepatide for weight loss also want to preserve or build lean muscle mass, which is where creatine's evidence-based benefits shine

As of 2025, Eli Lilly has not announced Phase 3 trials for oral tirzepatide, suggesting approval is at least 5-10 years away if the program proceeds successfully